Lung cancer, Non small cell lung cancer (NSCLC), Small cell lung cancer
Results
Phase 3
This trial wanted to see if the blood thinning drug dalteparin (Fragmin) could reduce the number of blood clots people had during treatment for lung cancer. And to find out if it could help stop cancer cells spreading through the bloodstream to other parts of the body.
Cancer Research UK supported this trial.
Recruitment start: 1 August 2007
Recruitment end: 16 November 2011
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Fergus Macbeth
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Pfizer
Velindre NHS Trust
Wales Cancer Trials Unit (WCTU)
This is Cancer Research UK trial number CRUK/06/007.
Last reviewed: 25 Sept 2016
CRUK internal database number: 590
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
